Exelixis, Inc. SEC filings EXEL
Exelixis, Inc. has 1,003 filings in SEC EDGAR's recent list, going back to Mar 2, 2018. Its latest annual report, Form 10-K, was filed on Feb 10, 2026 for the period ended Jan 2, 2026. The latest quarterly report (Form 10-Q) was filed on Oct 29, 2026, covering the quarter ended Oct 2, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (results of operations). The company's fiscal year ends on January 1.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Oct 29, 2026 | Oct 2, 2026 |
| 8-K |
Current report
Results of operations
|
Oct 29, 2026 | Oct 29, 2026 |
| 8-K |
Current report
Other events
|
Sep 11, 2026 | Sep 10, 2026 |
| 8-K |
Current report
Other events
|
Aug 31, 2026 | Aug 31, 2026 |
| S-8 | Employee stock plan registration | Aug 5, 2026 | — |
| 10-Q | Quarterly report | Aug 5, 2026 | Jul 3, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2026 | Aug 5, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 29, 2026 | May 26, 2026 |
| 10-Q | Quarterly report | May 5, 2026 | Apr 3, 2026 |
| 8-K |
Current report
Results of operations, Other events
|
May 5, 2026 | May 5, 2026 |
| DEFA14A | Additional proxy material | Apr 17, 2026 | — |
| DEFA14A | Additional proxy material | Apr 15, 2026 | — |
| DEF 14A | Proxy statement | Apr 15, 2026 | May 26, 2026 |
| 10-K | Annual report | Feb 10, 2026 | Jan 2, 2026 |
| 8-K |
Current report
Results of operations
|
Feb 10, 2026 | Feb 10, 2026 |
| 8-K |
Current report
Results of operations
|
Jan 12, 2026 | Jan 11, 2026 |
| 8-K |
Current report
Officer or director change, Other events
|
Nov 7, 2025 | Nov 4, 2025 |
| 10-Q | Quarterly report | Nov 4, 2025 | Oct 3, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
Nov 4, 2025 | Nov 4, 2025 |
| 8-K |
Current report
Officer or director change
|
Aug 29, 2025 | Aug 29, 2025 |
| 10-Q | Quarterly report | Jul 28, 2025 | Jul 4, 2025 |
| 8-K |
Current report
Results of operations
|
Jul 28, 2025 | Jul 28, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 2, 2025 | May 28, 2025 |
| 10-Q | Quarterly report | May 13, 2025 | Apr 4, 2025 |
| 8-K |
Current report
Results of operations
|
May 13, 2025 | May 13, 2025 |
| ARS | Annual report to shareholders | Apr 16, 2025 | Jan 3, 2025 |
| DEFA14A | Additional proxy material | Apr 16, 2025 | — |
| DEF 14A | Proxy statement | Apr 16, 2025 | May 28, 2025 |
| 8-K |
Current report
Officer or director change
|
Mar 31, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Other events
|
Feb 21, 2025 | Feb 20, 2025 |
| 10-K | Annual report | Feb 11, 2025 | Jan 3, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 11, 2025 | Feb 11, 2025 |
| 8-K |
Current report
Results of operations
|
Jan 13, 2025 | Jan 12, 2025 |
| 10-Q | Quarterly report | Oct 29, 2024 | Sep 27, 2024 |
| 8-K |
Current report
Results of operations
|
Oct 29, 2024 | Oct 29, 2024 |
| 8-K |
Current report
Other events
|
Oct 15, 2024 | Oct 15, 2024 |
| 8-K |
Current report
Other events
|
Oct 15, 2024 | Oct 14, 2024 |
| S-8 | Employee stock plan registration | Aug 6, 2024 | — |
| 10-Q | Quarterly report | Aug 6, 2024 | Jun 28, 2024 |
| 8-K |
Current report
Results of operations, Other events
|
Aug 6, 2024 | Aug 6, 2024 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 3, 2024 | May 30, 2024 |
| UPLOAD | Letter from the SEC | May 21, 2024 | — |
| 8-K |
Current report
Other events
|
May 20, 2024 | May 20, 2024 |
| CORRESP | Letter to the SEC | May 17, 2024 | — |
| 8-K |
Current report
Other events
|
May 10, 2024 | May 9, 2024 |
| 10-Q | Quarterly report | Apr 30, 2024 | Mar 29, 2024 |
| 8-K |
Current report
Results of operations
|
Apr 30, 2024 | Apr 30, 2024 |
| CORRESP | Letter to the SEC | Apr 29, 2024 | — |
| ARS | Annual report to shareholders | Apr 18, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 18, 2024 | — |
| DEF 14A | Proxy statement | Apr 18, 2024 | May 30, 2024 |
| CORRESP | Letter to the SEC | Apr 8, 2024 | — |
| 8-K |
Current report
Officer or director change
|
Mar 29, 2024 | Mar 27, 2024 |
| UPLOAD | Letter from the SEC | Mar 19, 2024 | — |
| 10-K | Annual report | Feb 6, 2024 | Dec 29, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 6, 2024 | Feb 6, 2024 |
| 8-K |
Current report
Results of operations, Exit or restructuring costs, Officer or director change, Other events
|
Jan 8, 2024 | Jan 2, 2024 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change
|
Dec 20, 2023 | Dec 14, 2023 |
| 10-Q | Quarterly report | Nov 1, 2023 | Sep 29, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 1, 2023 | Nov 1, 2023 |
| 8-K |
Current report
Officer or director change
|
Sep 19, 2023 | Sep 13, 2023 |
| 8-K |
Current report
Officer or director change
|
Aug 23, 2023 | Aug 23, 2023 |
| 10-Q | Quarterly report | Aug 1, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 1, 2023 | Aug 1, 2023 |
| 8-K |
Current report
Other events
|
Jul 24, 2023 | Jul 18, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 5, 2023 | May 31, 2023 |
| DEFA14A | Additional proxy material | May 17, 2023 | — |
| DFAN14A | Exelixis, inc. | May 15, 2023 | — |
| DEFA14A | Additional proxy material | May 15, 2023 | — |
| DFAN14A | Exelixis, inc. | May 11, 2023 | — |
| 10-Q | Quarterly report | May 9, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 9, 2023 | May 9, 2023 |
| DFAN14A | Exelixis, inc. | May 8, 2023 | — |
| DFAN14A | Exelixis, inc. | May 8, 2023 | — |
| DEFA14A | Additional proxy material | May 8, 2023 | — |
| 8-K |
Current report
Officer or director change, Other events
|
May 8, 2023 | May 7, 2023 |
| DFAN14A | Exelixis, inc. | May 3, 2023 | — |
| DEFC14A | Exelixis, inc. | May 3, 2023 | — |
| DEFA14A | Additional proxy material | May 2, 2023 | — |
| ARS | Annual report to shareholders | May 2, 2023 | Dec 30, 2022 |
| DEFA14A | Additional proxy material | May 1, 2023 | — |
| DEFC14A | Filing | May 1, 2023 | — |
| DFAN14A | Exelixis, inc. | Apr 25, 2023 | — |
| CT ORDER | Filing | Apr 25, 2023 | — |
| DFAN14A | Filing | Apr 24, 2023 | — |
| PRRN14A | Exelixis, inc. | Apr 21, 2023 | — |
| PREC14A | Filing | Apr 17, 2023 | — |
| DEFA14A | Additional proxy material | Apr 13, 2023 | — |
| 8-K |
Current report
Officer or director change, Other events
|
Apr 13, 2023 | Apr 12, 2023 |
| PREC14A | Exelixis, inc. | Apr 6, 2023 | — |
| DEFA14A | Additional proxy material | Apr 6, 2023 | — |
| DFAN14A | Exelixis, inc. | Apr 5, 2023 | — |
| 8-K |
Current report
Other events
|
Mar 22, 2023 | Mar 16, 2023 |
| 8-K |
Current report
Other events
|
Mar 20, 2023 | Mar 20, 2023 |
| 10-K | Annual report | Feb 7, 2023 | Dec 30, 2022 |
| 8-K |
Current report
Results of operations
|
Feb 7, 2023 | Feb 7, 2023 |
| 8-K |
Current report
Results of operations
|
Jan 9, 2023 | Jan 8, 2023 |
| 8-K |
Current report
Officer or director change
|
Dec 15, 2022 | Dec 15, 2022 |
| 10-Q | Quarterly report | Nov 1, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 1, 2022 | Nov 1, 2022 |
| 8-K |
Current report
Other events
|
Sep 2, 2022 | Sep 2, 2022 |
| S-8 | Employee stock plan registration | Aug 9, 2022 | — |
| 10-Q | Quarterly report | Aug 9, 2022 | Jul 1, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2022 | Aug 9, 2022 |
| 8-K |
Current report
Other events
|
Jul 19, 2022 | Jul 18, 2022 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 27, 2022 | May 25, 2022 |
| 10-Q | Quarterly report | May 10, 2022 | Apr 1, 2022 |
| 8-K |
Current report
Results of operations
|
May 10, 2022 | May 10, 2022 |
| CT ORDER | Filing | May 2, 2022 | — |
| DEFA14A | Additional proxy material | Apr 14, 2022 | — |
| DEF 14A | Proxy statement | Apr 14, 2022 | May 25, 2022 |
| 8-K |
Current report
Officer or director change
|
Apr 13, 2022 | Apr 11, 2022 |
| 8-K |
Current report
Other events
|
Feb 23, 2022 | Feb 23, 2022 |
| 10-K | Annual report | Feb 18, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations
|
Feb 17, 2022 | Feb 17, 2022 |
| 8-K |
Current report
Results of operations
|
Jan 10, 2022 | Jan 9, 2022 |
| 8-K |
Current report
Officer or director change
|
Dec 17, 2021 | Dec 16, 2021 |
| 10-Q | Quarterly report | Nov 2, 2021 | Oct 1, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 2, 2021 | Nov 2, 2021 |
| CT ORDER | Filing | Oct 5, 2021 | — |
| 10-Q | Quarterly report | Aug 5, 2021 | Jul 2, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2021 | Aug 5, 2021 |
| 8-K |
Current report
Other events
|
Jun 21, 2021 | Jun 17, 2021 |
| 8-K |
Current report
Officer or director change
|
Jun 21, 2021 | Jun 18, 2021 |
| CT ORDER | Filing | Jun 16, 2021 | — |
| CT ORDER | Filing | Jun 16, 2021 | — |
| 8-K |
Current report
Shareholder vote results
|
May 27, 2021 | May 26, 2021 |
| 8-K |
Current report
Other events
|
May 11, 2021 | May 7, 2021 |
| 10-Q | Quarterly report | May 6, 2021 | Apr 2, 2021 |
| 8-K |
Current report
Results of operations
|
May 6, 2021 | May 6, 2021 |
| DEFA14A | Additional proxy material | Apr 15, 2021 | — |
| DEF 14A | Proxy statement | Apr 15, 2021 | May 26, 2021 |
| 8-K |
Current report
Officer or director change
|
Mar 5, 2021 | Mar 4, 2021 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Mar 3, 2021 | Feb 25, 2021 |
| 10-K | Annual report | Feb 11, 2021 | Jan 1, 2021 |
| 8-K |
Current report
Results of operations
|
Feb 10, 2021 | Feb 10, 2021 |
| 8-K |
Current report
Officer or director change
|
Feb 5, 2021 | Feb 3, 2021 |
| 8-K |
Current report
Results of operations
|
Jan 11, 2021 | Jan 10, 2021 |
| 10-Q | Quarterly report | Nov 5, 2020 | Oct 2, 2020 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2020 | Nov 5, 2020 |
| S-8 | Employee stock plan registration | Aug 6, 2020 | — |
| 10-Q | Quarterly report | Aug 6, 2020 | Jul 3, 2020 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2020 | Aug 6, 2020 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 22, 2020 | May 20, 2020 |
| 8-K |
Current report
Other events
|
May 12, 2020 | May 11, 2020 |
| 10-Q | Quarterly report | May 5, 2020 | Apr 3, 2020 |
| 8-K |
Current report
Results of operations
|
May 5, 2020 | May 5, 2020 |
| CT ORDER | Filing | Apr 30, 2020 | — |
| CT ORDER | Filing | Apr 30, 2020 | — |
| 8-K |
Current report
Other events
|
Apr 20, 2020 | Apr 20, 2020 |
| DEFA14A | Additional proxy material | Apr 9, 2020 | — |
| DEF 14A | Proxy statement | Apr 9, 2020 | May 20, 2020 |
| 8-K |
Current report
Officer or director change
|
Mar 2, 2020 | Feb 27, 2020 |
| 10-K | Annual report | Feb 25, 2020 | Jan 3, 2020 |
| 8-K |
Current report
Results of operations
|
Feb 25, 2020 | Feb 25, 2020 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Feb 20, 2020 | Feb 20, 2020 |
| 8-K |
Current report
Results of operations
|
Jan 13, 2020 | Jan 12, 2020 |
| 8-K |
Current report
Material agreement
|
Dec 19, 2019 | Dec 18, 2019 |
| 10-Q | Quarterly report | Oct 30, 2019 | Sep 27, 2019 |
| 8-K |
Current report
Results of operations
|
Oct 30, 2019 | Oct 30, 2019 |
| 8-K |
Current report
Other events
|
Oct 7, 2019 | Oct 7, 2019 |
| 8-K |
Current report
Other events
|
Sep 26, 2019 | Sep 26, 2019 |
| 10-Q | Quarterly report | Jul 31, 2019 | Jun 28, 2019 |
| 8-K |
Current report
Results of operations
|
Jul 31, 2019 | Jul 31, 2019 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 20, 2019 | Jun 19, 2019 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results
|
May 23, 2019 | May 22, 2019 |
| DEFA14A | Additional proxy material | May 8, 2019 | — |
| DEFA14A | Additional proxy material | May 8, 2019 | — |
| 10-Q | Quarterly report | May 1, 2019 | Mar 29, 2019 |
| 8-K |
Current report
Results of operations
|
May 1, 2019 | May 1, 2019 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 25, 2019 | Apr 25, 2019 |
| DEFA14A | Additional proxy material | Apr 11, 2019 | — |
| DEF 14A | Proxy statement | Apr 11, 2019 | May 22, 2019 |
| 8-K |
Current report
Material agreement, New debt
|
Apr 5, 2019 | Apr 1, 2019 |
| PRE 14A | Preliminary proxy statement | Mar 28, 2019 | May 22, 2019 |
| CT ORDER | Filing | Mar 11, 2019 | — |
| 8-K |
Current report
Officer or director change
|
Mar 5, 2019 | Feb 28, 2019 |
| 10-K | Annual report | Feb 22, 2019 | Dec 28, 2018 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Feb 21, 2019 | Feb 14, 2019 |
| 8-K |
Current report
Results of operations
|
Feb 12, 2019 | Feb 12, 2019 |
| CT ORDER | Filing | Nov 19, 2018 | — |
| 10-Q | Quarterly report | Nov 1, 2018 | Sep 28, 2018 |
| 8-K |
Current report
Results of operations
|
Nov 1, 2018 | Nov 1, 2018 |
| CT ORDER | Filing | Aug 13, 2018 | — |
| S-8 POS | Filing | Aug 1, 2018 | — |
| S-8 POS | Filing | Aug 1, 2018 | — |
| S-8 POS | Filing | Aug 1, 2018 | — |
| S-8 POS | Filing | Aug 1, 2018 | — |
| S-8 POS | Filing | Aug 1, 2018 | — |
| S-8 POS | Filing | Aug 1, 2018 | — |
| S-8 POS | Filing | Aug 1, 2018 | — |
| S-8 POS | Filing | Aug 1, 2018 | — |
| S-8 POS | Filing | Aug 1, 2018 | — |
| S-8 POS | Filing | Aug 1, 2018 | — |
| S-8 POS | Filing | Aug 1, 2018 | — |
| S-8 POS | Filing | Aug 1, 2018 | — |
| S-8 POS | Filing | Aug 1, 2018 | — |
| S-8 POS | Filing | Aug 1, 2018 | — |
| S-8 POS | Filing | Aug 1, 2018 | — |
| S-8 POS | Filing | Aug 1, 2018 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- EXEL (Nasdaq)
- Fiscal year ends
- January 1
- Incorporated in
- DE
- Headquarters
- Alameda, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 939767
- Former names
- EXELIXIS INC (until Sep 12, 2012)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Neurocrine Biosciences Inc NBIX
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.